BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Visa
V
|
+$333M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$265M |
| 3 |
Motorola Solutions
MSI
|
+$222M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$220M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$193M |
Top Sells
| 1 |
Apple
AAPL
|
+$251M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$196M |
| 3 |
Alibaba
BABA
|
+$193M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$130M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| 1 | Technology | 14.35% |
| 2 | Financials | 12.02% |
| 3 | Consumer Discretionary | 9.44% |
| 4 | Healthcare | 8.58% |
| 5 | Industrials | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
BridgeBio Pharma
BBIO
$9.79B
| $70.8K | ﹤0.01% |
+3,298
| New | +$70.8K |
|
|
ALTA
2552
DELISTED
Altabancorp Common Stock
ALTA
| $70.7K | ﹤0.01% |
2,500
-12
| -0.5% | -$339 |
|
|
OPB
2553
DELISTED
Opus Bank Common Stock
OPB
| $70.5K | ﹤0.01% |
3,240
+1,029
| +47% | +$22.4K |
|
|
EXPR
2554
DELISTED
Express, Inc.
EXPR
| $70.5K | ﹤0.01% |
1,025
-303
| -23% | -$20.9K |
|
|
OMN
2555
DELISTED
OMNOVA Solutions Inc.
OMN
| $70.4K | ﹤0.01% |
6,995
+1,599
| +30% | +$16.1K |
|
2556
Digimarc
DMRC
$204M
| $70.4K | ﹤0.01% |
1,801
+478
| +36% | +$18.7K |
|
|
EIDX
2557
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $70.3K | ﹤0.01% |
1,955
+114
| +6% | +$4.1K |
|
|
PEI
2558
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $70.3K | ﹤0.01% |
819
-43
| -5% | -$3.69K |
|
|
STML
2559
DELISTED
Stemline Therapeutics, Inc.
STML
| $70K | ﹤0.01% |
6,729
+2,479
| +58% | +$25.8K |
|
|
CEO
2560
DELISTED
CNOOC Limited
CEO
| $70K | ﹤0.01% |
460
-1,163
| -72% | -$177K |
|
|
LGTY
2561
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $69.6K | ﹤0.01% |
4,636
+758
| +20% | +$11.4K |
|
2562
REX American Resources
REX
$1.01B
| $69.6K | ﹤0.01% |
2,736
+831
| +44% | +$21.1K |
|
|
EFC
2563
Ellington Financial
EFC
$1.34B
| $69.5K | ﹤0.01% |
3,845
+2,545
| +196% | +$46K |
|
|
HTB
2564
HomeTrust Bancshares, Inc.
HTB
$713M
| $69.3K | ﹤0.01% |
2,658
-44
| -2% | -$1.15K |
|
2565
Red Robin
RRGB
$121M
| $69K | ﹤0.01% |
2,076
-150,220
| -99% | -$5M |
|
2566
Bally's
BALY
$487M
| $68.9K | ﹤0.01% |
3,018
+2,847
| +1,665% | +$65K |
|
2567
Twist Bioscience
TWST
$1.53B
| $68.8K | ﹤0.01% |
2,882
+2,315
| +408% | +$55.3K |
|
|
COWN
2568
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $68.5K | ﹤0.01% |
4,453
-470
| -10% | -$7.23K |
|
2569
Wave Life Sciences
WVE
$1.11B
| $68.3K | ﹤0.01% |
3,329
+1,067
| +47% | +$21.9K |
|
|
PGNX
2570
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $68.1K | ﹤0.01% |
13,467
+4,142
| +44% | +$20.9K |
|
2571
Arrow Financial
AROW
$478M
| $68K | ﹤0.01% |
2,294
-49
| -2% | -$1.45K |
|
2572
TG Therapeutics
TGTX
$5.1B
| $67.8K | ﹤0.01% |
12,071
+5,099
| +73% | +$28.6K |
|
2573
Civitas Resources
CIVI
$3.02B
| $67.5K | ﹤0.01% |
3,015
+921
| +44% | +$20.6K |
|
|
LDL
2574
DELISTED
Lydall, Inc.
LDL
| $67.5K | ﹤0.01% |
2,709
-73
| -3% | -$1.82K |
|
2575
SpartanNash
SPTN
$897M
| $67.4K | ﹤0.01% |
5,697
-2,237
| -28% | -$26.5K |
|